Wild 20 | 152784-11-7 | xxxx

MedKoo Cat#: 581387 | Name: Wild 20

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Wild 20 is a breakdown product of G(M1) ganglioside; has antiplatelet effect & prolonged bleeding time without interfering with the coagulative or fibrinolytic processes.

Chemical Structure

Wild 20

CAS#152784-11-7

Theoretical Analysis

MedKoo Cat#: 581387

Name: Wild 20

CAS#: 152784-11-7

Chemical Formula: C53H97N3O28

Exact Mass: 1223.6259

Molecular Weight: 1224.35

Elemental Analysis: C, 51.99; H, 7.99; N, 3.43; O, 36.59

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Wild 20; Wild-20; Wild20; De-N-acetyllysoGM1;

IUPAC/Chemical Name

(2S,4S,5R,6S)-5-amino-2-(((2S,3R,4R,5S,6S)-2-(((2S,3S,4R,5R,6R)-6-(((2R,3S,Z)-2-amino-3-hydroxyicos-4-en-1-yl)oxy)-4,5-dihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-5-(((2S,3R,4R,5R,6R)-3-amino-5-hydroxy-6-(hydroxymethyl)-4-(((2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)oxy)-4-hydroxy-6-((1S,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-carboxylic acid

InChi Key

RINPOXNCRXGFAV-LPKLQDSVSA-N

InChi Code

InChI=1S/C53H97N3O28/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-26(62)25(54)24-75-49-41(71)39(69)43(31(22-60)78-49)80-51-42(72)47(84-53(52(73)74)18-27(63)33(55)46(83-53)35(65)28(64)19-57)44(32(23-61)79-51)81-48-34(56)45(37(67)30(21-59)76-48)82-50-40(70)38(68)36(66)29(20-58)77-50/h16-17,25-51,57-72H,2-15,18-24,54-56H2,1H3,(H,73,74)/b17-16-/t25-,26+,27+,28-,29-,30-,31+,32+,33-,34-,35+,36+,37+,38-,39-,40-,41-,42-,43-,44+,45-,46+,47-,48+,49-,50+,51+,53+/m1/s1

SMILES Code

C(\CCCCCCCCCCCCCCC)=C\[C@@H]([C@@H](CO[C@H]1[C@@H]([C@@H](O)[C@@H]([C@H](CO)O1)O[C@H]1[C@@H]([C@@H](O[C@@]2(C[C@H](O)[C@@H](N)[C@@H]([C@H]([C@@H](CO)O)O)O2)C(O)=O)[C@H]([C@H](CO)O1)O[C@H]1[C@H](N)[C@@H](O[C@@H]2O[C@@H]([C@H](O)[C@@H](O)[C@H]2O)CO)[C@H]([C@H](O1)CO)O)O)O)N)O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 1,224.35 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Pérez JA, Sánchez-García C, Díez C, Bartolomé DJ, Alonso ME, Gaudioso VR. Are parent-reared red-legged partridges (Alectoris rufa) better candidates for re-establishment purposes? Poult Sci. 2015 Oct;94(10):2330-8. doi: 10.3382/ps/pev210. Epub 2015 Sep 10. PubMed PMID: 26362976. 2: Di Minin E, Laitila J, Montesino-Pouzols F, Leader-Williams N, Slotow R, Goodman PS, Conway AJ, Moilanen A. Identification of policies for a sustainable legal trade in rhinoceros horn based on population projection and socioeconomic models. Conserv Biol. 2015 Apr;29(2):545-55. doi: 10.1111/cobi.12412. Epub 2014 Oct 20. PubMed PMID: 25331485; PubMed Central PMCID: PMC4405060. 3: Ogunkunle AT, Oyelakin TM, Enitan AO, Oyewole FE. A quantitative documentation of the composition of two powdered herbal formulations (antimalarial and haematinic) using ethnomedicinal information from ogbomoso, Nigeria. Evid Based Complement Alternat Med. 2014;2014:751291. doi: 10.1155/2014/751291. Epub 2014 Feb 20. PubMed PMID: 24701246; PubMed Central PMCID: PMC3950644. 4: Asami DK, McDonald RB, Hagopian K, Horwitz BA, Warman D, Hsiao A, Warden C, Ramsey JJ. Effect of aging, caloric restriction, and uncoupling protein 3 (UCP3) on mitochondrial proton leak in mice. Exp Gerontol. 2008 Dec;43(12):1069-76. doi: 10.1016/j.exger.2008.09.010. Epub 2008 Sep 30. PubMed PMID: 18852040; PubMed Central PMCID: PMC2614627. 5: Tubaro E, Borelli GP, Belogi L, Cavallo G, Santoni A, Mainiero F. Effect of a new de-N-acetyl-lysoglycosphingolipid on some tumour models. Eur J Pharmacol. 1995 Dec 29;294(2-3):555-63. PubMed PMID: 8750718. 6: Tubaro E, Croce C, Cavallo G, Belogi L, Guida G, Santiangeli C, Cifone MG, Santoni A, Mainiero F. In vitro and in vivo impact of a new glycosphingolipid on neutrophils. Agents Actions. 1994 Oct;42(3-4):107-13. PubMed PMID: 7879694. 7: Tubaro E, Santiangeli C, Cavallo G, Belogi L, Guida G, Croce C, Modesti A. Effect of a new de-N-acetyl-lysoglycosphingolipid on chemically-induced inflammatory bowel disease: possible mechanism of action. Naunyn Schmiedebergs Arch Pharmacol. 1993 Dec;348(6):670-8. PubMed PMID: 8133910. 8: Tubaro E, Belogi L, Croce C, Cavallo G, Guida G, Borelli GP. Antiplatelet effects of a new de-N-acetyl-lyso-glycosphingolipid. Eur J Pharmacol. 1993 Aug 2;248(2):175-83. PubMed PMID: 8223963.